First Trimester Exposure to Anxiolytic and Hypnotic Drugs and the Risks of Major Congenital Anomalies: A United Kingdom Population-Based Cohort Study
暂无分享,去创建一个
R. Hubbard | L. Smeeth | J. West | L. Tata | L. Ban | J. Gibson | P. Doyle | L. Fiaschi | R. Sokal
[1] A. Coomarasamy,et al. Antenatal and postnatal mental health , 2016 .
[2] S. Pilling,et al. Antenatal and postnatal mental health: summary of updated NICE guidance , 2014, BMJ : British Medical Journal.
[3] T. Coleman,et al. Completeness of Maternal Smoking Status Recording during Pregnancy in United Kingdom Primary Care Data , 2013, PloS one.
[4] L. Tata,et al. Potential of general practice data for congenital anomaly research: Comparison with registry data in the United Kingdom. , 2013, Birth defects research. Part A, Clinical and molecular teratology.
[5] Ronan A Lyons,et al. UK health performance: findings of the Global Burden of Disease Study 2010 , 2013, BDJ.
[6] C. Bellantuono,et al. Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview. , 2013, General hospital psychiatry.
[7] L. Brandt,et al. Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study , 2012, BMJ : British Medical Journal.
[8] L. Tata,et al. Impact of socioeconomic deprivation on maternal perinatal mental illnesses presenting to UK general practice. , 2012, The British journal of general practice : the journal of the Royal College of General Practitioners.
[9] J. West,et al. Live and Non-Live Pregnancy Outcomes among Women with Depression and Anxiety: A Population-Based Study , 2012, PloS one.
[10] F. Oyebode,et al. Psychotropics in pregnancy: safety and other considerations. , 2012, Pharmacology & therapeutics.
[11] L. Brandt,et al. Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects. , 2012, Archives of general psychiatry.
[12] N. Gilhus,et al. Pregnancy complications in patients with epilepsy , 2012, Current opinion in obstetrics & gynecology.
[13] C. Parker,et al. Causes of death among stillbirths. , 2011, JAMA.
[14] B. Källén,et al. Are Hypnotic Benzodiazepine Receptor Agonists Teratogenic in Humans? , 2011, Journal of clinical psychopharmacology.
[15] Lisa Szatkowski,et al. Can data from primary care medical records be used to monitor national smoking prevalence? , 2011, Journal of Epidemiology & Community Health.
[16] R. Charlton,et al. Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as Tools for Postmarketing Teratogen Surveillance , 2011, Drug safety.
[17] G. Koren,et al. The fetal safety of benzodiazepines: an updated meta-analysis. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[18] M. Cunnington,et al. Identifying Major Congenital Malformations in the UK General Practice Research Database (GPRD) , 2010, Drug safety.
[19] Richard A. Armstrong,et al. Sample size estimation and statistical power analyses , 2010 .
[20] I. Mylonas,et al. Managing hyperemesis gravidarum: a multimodal challenge , 2010, BMC medicine.
[21] A. Olshan,et al. Validation of neural tube defects in the full featured—general practice research database , 2008, Pharmacoepidemiology and drug safety.
[22] C. Hertzman,et al. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. , 2008, Birth defects research. Part B, Developmental and reproductive toxicology.
[23] R. Charlton,et al. Data Resources for Investigating Drug Exposure during Pregnancy and Associated Outcomes , 2008, Drug safety.
[24] B. Källén,et al. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations , 2007, Pharmacoepidemiology and drug safety.
[25] H A Guess,et al. The utility of the general practice research database to examine selected congenital heart defects: a validation study , 2007, Pharmacoepidemiology and drug safety.
[26] W. Bilker,et al. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research , 2007, Pharmacoepidemiology and drug safety.
[27] H. Guess,et al. Evaluation of the General Practice Research Database congenital heart defects prevalence: comparison to United Kingdom national systems. , 2007, Birth defects research. Part A, Clinical and molecular teratology.
[28] E. Horváth-Puhó,et al. Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: a case‐time‐control study , 2007, Pharmacoepidemiology and drug safety.
[29] Allan Donner,et al. The prevalence of stillbirths: a systematic review , 2006, Reproductive health.
[30] James W. Hardin,et al. Generalized Estimating Equations (GEE) , 2005 .
[31] H. Dolk. EUROCAT: 25 years of European surveillance of congenital anomalies , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.
[32] D. Mehta. British National Formulary (BNF) 51 , 2005 .
[33] Cemach. Confidential Enquiry into Maternal and Child Health , 2005 .
[34] J. Olsen,et al. A population-based case-control study of oral chlordiazepoxide use during pregnancy and risk of congenital abnormalities. , 2004, Neurotoxicology and teratology.
[35] M. Bonati,et al. Use of psychotropic drugs during pregnancy , 1993, European Journal of Clinical Pharmacology.
[36] H. Sørensen,et al. Short-Term Oral Diazepam Treatment during Pregnancy , 2003, Clinical drug investigation.
[37] J. Astbury,et al. Gender disparities in mental health , 2001 .
[38] U. Bergman,et al. Benzodiazepine use in pregnancy and major malformations or oral clefts , 1999, BMJ.
[39] C. Cates. Benzodiazepine use in pregnancy and major malformations or oral clefts. Pooled results are sensitive to zero transformation used. , 1999, British medical journal.
[40] J. Boughman,et al. Ebstein's malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington Infant Study Group. , 1994, Teratology.
[41] R. D'Amato,et al. Thalidomide is an inhibitor of angiogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[42] O. Heinonen,et al. Congenital heart disease in the offspring and maternal habits and home exposures during pregnancy. , 1992, Teratology.
[43] D. Black. HEALTH AND DEPRIVATION: Inequality and the north , 1988 .
[44] A. Czeizel. Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary. , 1987, Reproductive toxicology.
[45] S. Shapiro,et al. Lack of relation of oral clefts to diazepam use during pregnancy. , 1983, The New England journal of medicine.
[46] G. Oakley,et al. ASSOCIATION BETWEEN CLEFT LIP WITH OR WITHOUT CLEFT PALATE AND PRENATAL EXPOSURE TO DIAZEPAM , 1975, The Lancet.
[47] I. Saxén. Associations between oral clefts and drugs taken during pregnancy. , 1975, International journal of epidemiology.
[48] A. Blalock. Surgical treatment of pulmonary stenosis. , 1947, Lancet.